InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,571.44
(
0.08%
)
US TECH 100
19,842.80
(
-0.02%
)
Dow Jones
39,534.51
(
0.40%
)
Brent Oil
85.88
(
-0.73%
)
Bitcoin
55,671.78
(
-0.29%
)
Post# of 252509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: DewDiligence post# 223250

Friday, 01/18/2019 9:35:32 AM

Friday, January 18, 2019 9:35:32 AM

Post# of 252509

The need remains for anything that works in sarcoma (#msg-144921709).



The problem is that "sarcoma" is used as an umbrella for a very molecularly diverse set of tumors. I don't think any single drug will work for sarcoma overall.

The TRK inhibitors work incredibly well in sarcoma--but of course patients have to have a mutation in NTRK.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up